Latest News
Sunday share tips: N Brown Group, Foxtons
The Financial Mail on Sunday's Midas column touted a raft of shares which it expected would benefit from the fight against obesity as well as the associated, and sometimes fatal, health risks.
WHO warns of potential 'catastrophic moral failure' in vaccine rollouts
The head of the World Health Organisation called for what he said would be a more equitable distribution of Covid-19 vaccines globally, warning that it was more important than ever given the appearance of new strains of the novel coronavirus.
Tuesday preview: Goldman Sachs, Bank of America, Centamin in focus
The market spotlight on Tuesday will fall on US banking heavyweights Bank of America and Goldman Sachs, as they release their fourth quarter earnings.
UK film industry asks government to provide support for struggling cinemas
A group of high profile names in the film industry have written an open letter calling for government support cinemas that are struggling due to the onslaught of the pandemic.
London close: Stocks mixed amid Covid-19 lockdown consternation
London stocks closed in a mixed state on Monday as investors mulled the latest data out of China, with travel and leisure shares under the cosh amid concerns about the Covid-19 crisis.
FTSE 250 movers: Genus boosted by China, Chemring wanted as Cyber Security play
London's second-tier index was trading slightly higher at the start of the week, with risk appetite buoyed by what little macroeconomic data was available given that Wall Street was closed in observance of the Martin Luther King Jr. holiday.
Director dealings: Globaldata CEO lowers stake
Globaldata revealed on Monday that chief executive officer Michael Danson had offloaded 1. 0m ordinary shares in the AIM-listed data and analytics firm.
FTSE 100 movers: Defensives slip, Banks wanted
The top-flight index was trading slightly lower in later afternoon trading, weighed down slightly by interest rate sensitive and defensive stocks such as BT Group, United Utilities and Hikma Pharmaceuticals.
Westmount Energy buys stake in JHI Associates
Westmount Energy has purchased 287,500 shares in JHI Associates for CAD 0. 72m (£0. 42m), it announced on Monday.
Broker tips: Paragon, Chemring, Blue Prism
Analysts at Canaccord Genuity hiked their target price on diversified financials group Paragon from 454. 0p to 548. 0p on Monday, pointing to the company's "exemplary track record" in terms of asset quality and operating performance throughout economic cycles.
AEX Gold makes 'significant progress' at Nalunaq
Greenland-focussed gold company AEX Gold updated the market on the development of the Nalunaq property in South Greenland on Monday, reporting that it remained on target and was making “significant progress”, with the award of key procurement packages.
Goldstone Resources reaches settlement with ex-director
Gold exploration and development company Goldstone Resources has reached an agreement with a former director, it announced on Monday, for full and final settlement of damages awarded by the South African Labour Court (the "Court") in December 2018.
Shellfish lorries park near Downing Street in protest over Brexit chaos
At least 10 shellfish lorries are parked on roads near Downing Street and the British parliament on Monday in protest over the chaos at the border after Brexit.
Kuaishou's Hong Kong IPO could value company at $60bn
Kuaishou’s initial public offering on the Hong Kong stock exchange could see the Chinese online short video company valued at $60bn.
Tertiary Minerals stakes claims over new copper project
Tertiary Minerals has staked claims over a new copper exploration project at Brunton Pass in Nevada, it announced on Monday.
JPM says investors too gloomy on company earnings
Investors are too pessimistic about prospects for company earnings with positive implications for European banks and other cyclical shares, JP Morgan said.
Canacord raises target price on Paragon Banking
Analysts at Canaccord Genuity hiked their target price on diversified financials group Paragon from 454. 0p to 548. 0p on Monday, pointing to the company's "exemplary track record" in terms of asset quality and operating performance throughout economic cycles.
Faron gets Traumakine funding from US Department of Defense
Clinical-stage biopharmaceuticals company Faron Pharmaceuticals announced on Monday that the US Department of Defense (DoD) has selected the ‘HIBISCUS’ study to receive $6. 1m (£4. 5m) of funding under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
Europe midday: Stocks flat as covid curbs hit sentiment
European stocks were flat at midday with investors ignoring positive China GDP data, while the termination of merger talks between French retailer Carrefour and Canada's Alimentation Couche-Tard also dampened sentiment.